Impact of ketamine on learning and memory function, neuronal apoptosis and its potential association with miR-214 and PTEN in adolescent rats

PLoS ONE

Volumn 9, Issue 6, 2014, Pages

  Wang, Ji ^a,c   Zhou, Min ^a   Wang, Xiaobin ^a   Yang, Xiaoling ^a   Wang, Maohua ^a   Zhang, Chunxiang ^b   Zhou, Shuzhi ^a   Tang, Ni ^a  

^a SOUTHWEST MEDICAL UNIVERSITY   (China)

^b RUSH MEDICAL COLLEGE   (United States)

^c AFFILIATED HOSPITAL OF NORTH SICHUAN MEDICAL COLLEGE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

KETAMINE; MICRORNA; MICRORNA 214; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; MIRN214 MICRORNA,RAT;

ADOLESCENT; ANIMAL EXPERIMENT; APOPTOSIS; ARTICLE; BRAIN CORTEX; CONTROLLED STUDY; DOWN REGULATION; HIPPOCAMPUS; IMMUNOHISTOCHEMISTRY; LEARNING DISORDER; MALE; MEMORY DISORDER; MORRIS WATER MAZE TEST; NERVE DEGENERATION; NICK END LABELING; NONHUMAN; OPEN FIELD TEST; PROTEIN EXPRESSION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING; AGING; ANIMAL; CYTOLOGY; DOSE RESPONSE; DRUG EFFECTS; GENETICS; HIPPOCAMPAL CA1 REGION; MAZE TEST; MEMORY; METABOLISM; NERVE CELL; SPATIAL MEMORY; SPRAGUE DAWLEY RAT; SWIMMING;

AGING; ANIMALS; APOPTOSIS; CA1 REGION, HIPPOCAMPAL; CEREBRAL CORTEX; DOSE-RESPONSE RELATIONSHIP, DRUG; KETAMINE; MALE; MAZE LEARNING; MEMORY; MICRORNAS; NEURONS; PTEN PHOSPHOHYDROLASE; RATS; RATS, SPRAGUE-DAWLEY; SPATIAL MEMORY; SWIMMING;

EID: 84902675087     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0099855     Document Type: Article

References (39)

1. Kohrs R, Durieux ME (1998) Ketamine: teaching an old drug new tricks. Anesth Analg 87:1186-1193. (Pubitemid 28501183)
2. Wang XB, Yang YL, Zhou X, Wu JL, Li Jl, et al. (2011) Propofol pretreatment increases antidepressant-like effects induced by acute administration of ketamine in rats receiving forced swimming test. Psychiatry Research 85: 248-253.
3. Kos T, Popik P, Pietraszek M, Schäfer D, Danysz W, et al. (2006) Effect of 5- HT3 receptor antagonist MDL 72222 on behaviors induced by ketamine in rats and mice. Eur Neuropsychopharmacol 16: 297-310.
4. Maeng S, Zarate CA Jr, Du J, Schloesser RJ, McCammon J, et al. (2008) Cellular mechanisms underlying the antidepressant effects of ketamine: role of alphaamino- 3-hydroxy-5-methylisoxazole-4-propionic acid receptors. Biological Psychiatry 63:349-352. (Pubitemid 351146651)
5. Garcia LS, Comim CM, Valvassori SS, Réus GZ, Barbosa LM, et al. (2008) Acute administration of ketamine induces antidepressant-like effects in the forced swimming test and increases BDNF levels in the rat hippocampus. Prog Neuropsychopharmacology Biological Psychiatry 32: 140-144.
6. Zarate CA, Singh JB, Carlson PJ, Brutsche NE, Ameli R, et al. (2006) A randomized trial of an N-methyl-d-aspartate antagonist in treatment-resistant major depression. Archives of General Psychiatry 63: 856-864. (Pubitemid 44188478)
7. Wang XB, Chen YL, Zhou X, Liu FH, Zhang T, et al. (2012) Effects of propofol and ketamine as the combined anesthesia for electroconvulsive therapy in patients with depressive disorder. J of ECT 28:128-132.
8. Ikonomidou C, Bosch F, Miksa M, Bittigau P, Vöckler J, et al. (1999) Blockade of NMDA receptors and apoptotic neurodegeneration in the developing brain. Science 283:70-74. (Pubitemid 29044848)
9. Campbell LL, Tyson JA, Stackpole EE, Hokenson KE, Sherrill H, et al. (2011) Assessment of general anesthetic cytotoxicity in murine cortical neurones in dissociated culture. Toxicology 283: 1-7.
10. Gomes LM, Garcia JB, Ribamar JS Jr, Nascimento AG (2011) Neurotoxicity of subarachnoid preservative-free S(+)-ketamine in dogs. Pain Physician 14: 83-90.
11. Paule MG, Li M, Allen RR, Liu F, Zou X, et al. (2011) Ketamine anesthesia during the first week of life can cause long-lasting cognitive deficits in rhesus monkeys. Neurotoxicol Teratol 33: 220-230.
12. Chen K and Rajewsky N (2007) The evolution of gene regulation by transcription factors and microRNAs. Nat Rev Genet 8: 93-103. (Pubitemid 46122839)
13. Lewis BP, Burge CB, Bartel DP (2005) Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 120:15-20. (Pubitemid 40094598)
14. Yang H, Kong W, He L, Zhao JJ, O'Donnell JD, et al. (2008) MicroRNA expression profiling in human ovarian cancer:miR-214 induces cell survival and cisplatin resistance by targeting PTEN. Cancer Res 68: 425-433. (Pubitemid 351380068)
15. Zhang ZC, Li YY, Wang HY, Fu S, Wang XP, et al. (2014) Knockdown of miR-214 promotes apoptosis and inhibits cell proliferation in nasopharyngeal carcinoma. Plos One 9:e86149.
16. Schwarzenbach H, Milde-Langosch K, Steinbach B, Müller V, Pantel K (2012) Diagnostic potential of PTEN-targeting miR-214 in the blood of breast cancer patients. Breast Cancer Res Treat 134: 933-941.
17. Kitagishi Y, Matsuda S (2013) Redox regulation of tumor suppressor PTEN in cancer and aging. Int J Mol Med 31: 511-515.
18. Li X, Li Z, Li N, Qi J, Fan K, et al. (2013) MAGI2 enhances the sensitivity of BEL-7404 human hepatocellular carcinoma cells to staurosporine-induced apoptosis by increasing PTEN stability. Int J Mol Med 32:439-447.
19. Shi Y, Paluch BE, Wang X, Jiang X (2012) PTEN at a glance. J Cell Sci 125: 4687-4692.
20. Song MS, Salmena L, Pandolfi PP (2012) The functions and regulation of the PTEN tumour suppressor. Nat Rev Mol Cell Biol 13: 283-296.
21. Zhang QG, Wu DN, Han D, Zhang GY (2007) Critical role of PTEN in the coupling between PI3K/Akt and JNK1/2 signaling in ischemic brain injury. FEBS Lett 581: 495-505. (Pubitemid 46149625)
22. Lin C, Durieux ME (2005) Ketamine and kids: an update. Paediatr Anaesth 15: 91-97. (Pubitemid 40269299)
23. Vutskits L, Gascon E, Kiss JZ (2007) Effects of ketamine on the developing central nervous system. Ideggyogy Sz 60:109-112.
24. Huang LN, Liu Y, Jin W, Ji X, Dong Z (2012) Ketamine potentiates hippocampal neurodegeneration and persistent learning and memory impairment through the PKCc-ERK signaling pathway in the developing brain. Brain Res 1476: 164-171.
25. Evans AM (1986) Age at puberty and first litter size in early and late paired rats. Biology of Reproduction 34: 322-326.
26. Waterman AE, Livingston A (1978) Effects of age and sex on ketamine anaesthesia in the rat. Br J Anaesth 50:885-889. (Pubitemid 9063434)
27. Schmid RL, Sandler AN, Katz J (1999) Use and efficacy of low-dose ketamine in the management of acute postoperative pain: a review of current techniques and outcomes. Pain 82:111-125. (Pubitemid 29317524)
28. Veilleux-Lemieux D, Castel A, Carrier D, Beaudry F, Vachon P (2013) Pharmacokinetics of ketamine and xylazine in young and old sprague-dawley rats. Journal of the American Association for Laboratory Animal Science 52:567-570.
29. Wang J, Goffer Y, Xu D, Tukey DS, Shamir DB, et al. (2011) A single subanesthetic dose of ketamine relieves depression like behaviors induced by neuropathic pain in rats. Anesthesiology 115: 812-821.
30. Morris R (1984) Developments of a water-maze procedure for studying spatial learning in the rat. J Neurosci Methods 11: 47-60.
31. Morris RG, Garrud P, Rawlins JN, O'Keefe J (1982) Place navigation impaired in rats with hippocampal lesions. Nature 297: 681-683. (Pubitemid 12096189)
32. Becker A and Grecksch G (2004) Ketamine-induced changes in rat behaviour: a possible animal model of schizophrenia. Test of predictive validity. Progress in Neuro - Psychopharmacology & Biological Psychiatry 28: 1267-1277. (Pubitemid 39592924)
33. Gama CS, Canever L, Panizzutti B, Gubert C, Stertz L, et al. (2012) Effects of omega-3 dietary supplement in prevention of positive, negative and cognitive symptoms: A study in adolescent rats with ketamine-induced model of schizophrenia. Schizophrenia Research 141: 162-167.
34. Straiko MM, Young C, Cattano D, Creeley CE, Wang H, et al. (2009) Lithium protects against anesthesia-induced developmental neuroapoptosis. Anesthesiology 110: 862-868.
35. Zou X, Patterson TA, Divine RL, Sadovova N, Zhang X, et al. (2009a) Prolonged exposure to ketamine increases neurodegeneration in the developing monkey brain. Int J Dev Neurosci 27: 727-731.
36. Zou X, Patterson TA, Sadovova N, Twaddle NC, Doerge DR, et al. (2009b) Potential neurotoxicity of ketamine in the developing rat brain. Toxicol Sci 108:149-158.
37. Hayashi H, Dikkes P, Soriano SG (2002) Repeated administration of ketamine may lead to neuronal degeneration in the developing rat brain. Paediatr Anaesth 12: 770-774.
38. Ambros V (2004) The functions of animal microRNAs. Nature 431:350-355.
39. Zhang C (2008) MicroRNomics: a newly emerging approach for disease biology. Physiol Genomics 33:139-147.